Ovarian Carcinoma — Trials

Ovarian Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

895 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06341907	Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC	recruiting	Phase 2 / Phase 3	10	Second Affiliated Hospital of Wenzhou Medical UniversityOTHER	1	Apr 2, 2024	clinicaltrials
NCT04716686	Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma	recruiting	Phase 2	83	Shandong UniversityOTHER	1	Jan 5, 2024	clinicaltrials